MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202418059023 A) filed by The George Institute For Global Health on August 05, 2024, for Low-Dose Triple Combination Formulation.
Inventors include Rodgers, Anthony; and Macmahon, Stephen.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: Pharmaceutical compositions useful in the treatment of metabolic disorders including diabetes, the compositions comprising a) a dipeptidyl peptidase IV (DPP IV) inhibitor such as sitagliptin, b) a biguanide such as metformin, and c) a sulfonylurea such as glimepiride, wherein each one of the DPPIV inhibitor, biguanide and sulfonylurea are at a dose that is at about 20-75% of the lowest diabetes therapeutic dose (LDTD).
Disclaimer: Curated by HT Syndication.
